Societe Generale’s Amgen AMGN Stock Holding History

Societe Generale’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$600K	Buy	+199,200	New	+$31M	﹤0.01%	1603

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Societe Generale's AMGN Position: Q2 2016 in Review

Societe Generale opened a new position in Amgen (AMGN) in Q2 2016: 73,081 shares worth $11.1M. The stake represents 0.08% of the portfolio and ranks #188 among its holdings.

1,472 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

Societe Generale held 73,081 shares of Amgen worth $11.1M as of Q2 2016.
Amgen was a new Societe Generale position in Q2 2016.
Amgen made up 0.08% of Societe Generale's portfolio in Q2 2016, its #188 holding.
1,472 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.